These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The developmental stage of the medulloblastoma cell-of-origin restricts Sonic hedgehog pathway usage and drug sensitivity. Smit MJ; Martini TEI; Armandari I; Bočkaj I; Zomerman WW; de Camargo Magalhães ES; Siragna Z; Meeuwsen TGJ; Scherpen FJG; Schoots MH; Ritsema M; den Dunnen WFA; Hoving EW; Paridaen JTML; de Haan G; Guryev V; Bruggeman SWM J Cell Sci; 2022 Jun; 135(11):. PubMed ID: 35535520 [TBL] [Abstract][Full Text] [Related]
26. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Menyhárt O; Győrffy B Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698 [TBL] [Abstract][Full Text] [Related]
28. Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysis. Lou E; Nelson AC; Kool M Cancer Biol Ther; 2019; 20(11):1398-1402. PubMed ID: 31423907 [TBL] [Abstract][Full Text] [Related]
30. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781 [TBL] [Abstract][Full Text] [Related]
31. Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen. Baroni LV; Sampor C; Gonzalez A; Lubieniecki F; Lamas G; Rugilo C; Bartels U; Heled A; Smith KS; Northcott PA; Bouffet E; Alderete D; Ramaswamy V Neuro Oncol; 2020 Dec; 22(12):1873-1881. PubMed ID: 32413139 [TBL] [Abstract][Full Text] [Related]
32. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma. Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637 [TBL] [Abstract][Full Text] [Related]
33. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma. Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257 [TBL] [Abstract][Full Text] [Related]
34. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822 [TBL] [Abstract][Full Text] [Related]
35. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation. Cambruzzi E Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169 [TBL] [Abstract][Full Text] [Related]
36. Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation. Tan IL; Wojcinski A; Rallapalli H; Lao Z; Sanghrajka RM; Stephen D; Volkova E; Korshunov A; Remke M; Taylor MD; Turnbull DH; Joyner AL Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3392-3397. PubMed ID: 29531057 [TBL] [Abstract][Full Text] [Related]
38. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Zhukova N; Ramaswamy V; Remke M; Pfaff E; Shih DJ; Martin DC; Castelo-Branco P; Baskin B; Ray PN; Bouffet E; von Bueren AO; Jones DT; Northcott PA; Kool M; Sturm D; Pugh TJ; Pomeroy SL; Cho YJ; Pietsch T; Gessi M; Rutkowski S; Bognar L; Klekner A; Cho BK; Kim SK; Wang KC; Eberhart CG; Fevre-Montange M; Fouladi M; French PJ; Kros M; Grajkowska WA; Gupta N; Weiss WA; Hauser P; Jabado N; Jouvet A; Jung S; Kumabe T; Lach B; Leonard JR; Rubin JB; Liau LM; Massimi L; Pollack IF; Shin Ra Y; Van Meir EG; Zitterbart K; Schüller U; Hill RM; Lindsey JC; Schwalbe EC; Bailey S; Ellison DW; Hawkins C; Malkin D; Clifford SC; Korshunov A; Pfister S; Taylor MD; Tabori U J Clin Oncol; 2013 Aug; 31(23):2927-35. PubMed ID: 23835706 [TBL] [Abstract][Full Text] [Related]
39. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma. Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241 [TBL] [Abstract][Full Text] [Related]
40. Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model. Niesen J; Ohli J; Sedlacik J; Dührsen L; Hellwig M; Spohn M; Holsten T; Schüller U Cancer Lett; 2020 May; 477():10-18. PubMed ID: 32112900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]